|
US3809767A
(en)
|
1969-05-12 |
1974-05-07 |
Griffith Laboratories |
Methods of making vegetable protein concentrates
|
|
AU1589492A
(en)
|
1991-03-01 |
1992-10-06 |
Warner-Lambert Company |
Starch-based controlled release compositions
|
|
US20120164306A1
(en)
|
1993-08-03 |
2012-06-28 |
Girsh Leonard S |
Process for preparing hypoallergenic and reduced fat foods
|
|
JP3445593B2
(ja)
|
1994-09-10 |
2003-09-08 |
株式会社林原生物化学研究所 |
ペプチドとその用途
|
|
US20020018778A1
(en)
|
1999-12-06 |
2002-02-14 |
Caplan Michael J. |
Passive desensitization
|
|
EP1272213B1
(en)
|
2000-04-06 |
2006-03-08 |
SEER Pharmaceuticals, LLC. |
Microbial delivery system
|
|
WO2004047793A1
(en)
|
2002-11-26 |
2004-06-10 |
Alk-Abelló A/S |
Pharmaceutical allergen product
|
|
CA2516291C
(en)
|
2003-02-28 |
2012-02-14 |
Alk-Abello A/S |
Dosage form having a saccharide matrix
|
|
EP2545931A1
(en)
|
2004-03-19 |
2013-01-16 |
Herbs Spring, LLC |
Herbal therapy for the treatment of food allergy
|
|
ATE524561T1
(de)
|
2004-04-06 |
2011-09-15 |
Sinai School Medicine |
Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
|
|
WO2007075171A1
(en)
|
2005-12-28 |
2007-07-05 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical formulations of fenofibrate having improved bioavailability
|
|
US8309088B2
(en)
|
2007-08-10 |
2012-11-13 |
Regeneron Pharmaceuticals, Inc. |
Method of treating osteoarthritis with an antibody to NGF
|
|
BRPI0920465A2
(pt)
|
2008-10-02 |
2018-03-20 |
Salix Pharmaceuticals, Inc. |
metodo de tratamento de encefalopatia hepática
|
|
CN102215825A
(zh)
|
2008-11-19 |
2011-10-12 |
安万托特性材料股份有限公司 |
可直接压制的颗粒状的基于微晶纤维素的赋形剂、其制备方法及应用
|
|
WO2010069595A1
(en)
|
2008-12-19 |
2010-06-24 |
Merz Pharma Gmbh & Co. Kgaa |
1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
|
|
US8329208B2
(en)
|
2009-07-28 |
2012-12-11 |
Methylation Sciences International Srl |
Pharmacokinetics of S-adenosylmethionine formulations
|
|
EP2364690A1
(en)
|
2010-02-12 |
2011-09-14 |
Centro De Ingenieria Genetica Y Biotecnologia |
Orally administrable pharmaceutical pellet of epidermal growth factor
|
|
JP5800527B2
(ja)
|
2010-03-30 |
2015-10-28 |
日東電工株式会社 |
安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
|
|
AR081776A1
(es)
|
2010-06-30 |
2012-10-17 |
Novartis Ag |
Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
|
|
GB201104537D0
(en)
|
2011-03-17 |
2011-05-04 |
Cambridge Entpr Ltd |
Treatment for peanut allergy
|
|
EP2750705B1
(en)
|
2011-08-31 |
2022-11-16 |
Perosphere Technologies Inc. |
Methods for effectively and rapidly desensitizing allergic patients
|
|
WO2013087119A1
(en)
|
2011-12-16 |
2013-06-20 |
Hal Allergy Holding B.V. |
Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
|
|
PL2802333T3
(pl)
|
2012-01-13 |
2020-09-07 |
Chr. Hansen A/S |
Lactobacillus rhamnosus i Bifidobacterium animalis subsp. lactis do stosowania dla zapobiegania lub leczenia zakażeń górnych dróg oddechowych
|
|
MX2015010315A
(es)
|
2013-03-14 |
2016-04-13 |
Aimmune Therapeutics Inc |
Fabricacion de formulaciones de mani para desensibilizacion oral.
|
|
WO2014159609A1
(en)
|
2013-03-14 |
2014-10-02 |
Allergen Research Corporation |
Peanut formulations and uses thereof
|
|
CA2907915C
(en)
|
2013-04-03 |
2023-03-07 |
Allertein Therapeutics, Llc |
Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
|
|
US9456628B2
(en)
|
2013-06-13 |
2016-10-04 |
D&E Gillespie Enterpries LLC |
Methods and products to provide oral nutritional care to subjects with dementia
|
|
US20150343075A1
(en)
|
2014-06-02 |
2015-12-03 |
Aimmune Therapeutics |
Placebo formulations and uses thereof
|
|
JP6910946B2
(ja)
|
2014-08-25 |
2021-07-28 |
アイミューン セラピューティクス，インコーポレイテッド |
タマゴのタンパク質製剤およびその製造方法
|
|
KR102234319B1
(ko)
|
2014-09-04 |
2021-04-01 |
헬신 헬쓰케어 에스.에이. |
아나모렐린 기반의 의학적 치료
|
|
AU2015315628A1
(en)
|
2014-09-08 |
2017-04-20 |
Cephalon, Inc. |
Use of reslizumab to treat moderate to severe eosinophilic asthma
|
|
WO2016138030A2
(en)
|
2015-02-23 |
2016-09-01 |
Antera Therapeutics Inc. |
Compositions and methods for tolerizing the immune system to allergens
|
|
CN107709321A
(zh)
*
|
2015-04-28 |
2018-02-16 |
盐野义制药株式会社 |
经取代的多环性吡啶酮衍生物及其前药
|
|
CN110381749A
(zh)
|
2017-01-13 |
2019-10-25 |
艾慕恩治疗公司 |
坚果粉的制造方法和用于口服免疫疗法的配方
|
|
FR3062797B1
(fr)
|
2017-02-10 |
2025-03-07 |
Centre Hospitalier Et Univ De Clermont Ferrand |
Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide
|
|
US11369676B2
(en)
|
2017-11-02 |
2022-06-28 |
Société des Produits Nestlé S.A. |
Methods of oral immunotherapy
|
|
US11406563B2
(en)
|
2018-07-27 |
2022-08-09 |
Société des Produits Nestlé S.A. |
Oral immunotherapy unit dose dispensing systems and methods
|
|
USD866322S1
(en)
|
2018-07-27 |
2019-11-12 |
Aimmune Therapeutics, Inc. |
Medicine folio
|
|
USD866320S1
(en)
|
2018-07-27 |
2019-11-12 |
Aimmune Therapeutics, Inc. |
Box of boxes for dispensing medicine
|
|
USD866321S1
(en)
|
2018-07-27 |
2019-11-12 |
Aimmune Therapeutics, Inc. |
Box of boxes for dispensing medicine
|
|
US12433945B2
(en)
|
2018-08-16 |
2025-10-07 |
Société des Produits Nestlé S.A. |
Peanut oral immunotherapy with maintenance dose
|
|
AU2019401576A1
(en)
|
2018-12-17 |
2021-06-24 |
Société des Produits Nestlé S.A. |
Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
|
|
JP7536035B2
(ja)
|
2019-03-22 |
2024-08-19 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
ピーナツに対する経口免疫療法における全身性アレルギー応答リスク評価
|
|
CA3137295A1
(en)
|
2019-05-10 |
2020-11-19 |
Aimmune Therapeutics, Inc. |
Methods for improving the quality of life of a patient with a peanut allergy
|